Procathepsin D as a Tumor Marker, Anti-Cancer Drug or Screening Agent

E-ISSN： 1875-5992|12|2|172-175

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.12, Iss.2, 2012-02, pp. : 172-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rodent Tumor Models for Anti-cancer Drug Testing: An Overview

By Kerbel R.S.

Cancer and Metastasis Reviews, Vol. 17, Iss. 3, 1998-01 ,pp. : 261-261

Springer Publishing Company

Access to resources Recommend Favorite

Use of a Surrogate Marker (Human Secreted Alkaline Phosphatase) to Monitor in Vivo Tumor Growth and Anticancer Drug Efficacy in Ovarian Cancer Xenografts

By Bao R. Selvakumaran M. Hamilton T.C.

Gynecologic Oncology, Vol. 78, Iss. 3, 2000-09 ,pp. : 373-379

Elsevier

Access to resources Recommend Favorite

Anti-Cancer Agent-Induced Nephrotoxicity

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 7, 2014-01 ,pp. : 921-927

Bentham Science Publishers

Access to resources Recommend Favorite

Doxycycline as Potential Anti-cancer Agent

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 17, Iss. 12, 2018-01 ,pp. : 1617-1623

Bentham Science Publishers

Access to resources Recommend Favorite

Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 6, 2012-07 ,pp. : 678-685

Bentham Science Publishers

Access to resources Recommend Favorite